SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-21-011231
Filing Date
2021-04-01
Accepted
2021-04-01 16:07:19
Documents
7
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 PRE14A nc10022480x1_pre14a.htm PRE 14A 1228058
2 logo_seelostherapeutics.jpg GRAPHIC 35790
3 nc10022480x1_annexbimg0x1.jpg GRAPHIC 1046900
4 nc10022480x1_annexbimg0x2.jpg GRAPHIC 920019
5 nc10022480x1_annexbimg0x3.jpg GRAPHIC 948688
6 nc10022480x1_annexbimg04.jpg GRAPHIC 867652
7 sig_rajmehra.jpg GRAPHIC 14562
  Complete submission text file 0001140361-21-011231.txt   6507482
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-22245 | Film No.: 21798037
SIC: 2834 Pharmaceutical Preparations